Recently initiated a pre-clinical trial with CollPlant's rhCollagen-based regenerative breast implants, printed with Stratasys' Origin® 3D printer that are 200cc in volume Breast implants could address a $3.0 billion market opportunity Cash and cash equivalents balance as of June 30, 2024 was $18.9 million Conference call to... Read More